Medtronic announces executive changes

GALWAY, Ireland – Medtronic has announced that Ryan Weispfenning, vice president and head of investor relations, will join its diabetes business to establish and lead the investor relations function for MiniMed, the planned new diabetes company. He brings more than 25 years of experience with Medtronic to his new role. “After leading Medtronic investor relations for the past decade, I am now honored to help establish the investor relations function for MiniMed as we prepare for its intended separation into an independent, public company,” said Weispfenning. “This is a pivotal moment for the diabetes business, and I look forward to partnering with the MiniMed leadership team and engaging with the investor community to articulate our long-term strategy, growth opportunities and commitment to improving outcomes for people living with diabetes worldwide.” Medtronic also announced that Ingrid Goldberg will join Medtronic as vice president and head of investor relations. Goldberg brings more than 20 years of industry experience, spanning the financial, medical device and life science sectors, most recently as vice president of finance and investor relations at Novocure, where she led the investor relations, communications, and business development functions. “I am thrilled to join Medtronic, an organization whose work transforms patient lives every day,” said Goldberg. “The company’s compelling product portfolio is inspiring, and I am eager to share the progress and innovation that define Medtronic and the people we serve. It is a privilege to contribute to a company so deeply committed to improving human health.” 

• Related: Medtronic to split off diabetes biz